BridgeBio Pharma, Inc. earnings per share and revenue

BBIO earnings per share for the last quarter are -0.86 USD whereas the estimation was -1.00 USD which accounts for 14.28% surprise. Company revenue for the same period amounts to 2.73 M USD despite the estimated figure of 1.68 M USD. Estimated earnings per share for the next quarter are -1.11 USD, and revenue is expected to reach 4.57 M USD. Also watch annual changes over time to get a bigger picture of BBIO earnings per share and revenue dynamics.